What do systematic reviews say?

372 questions · 374 findings · 178 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 374 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Rilonacept vs indomethacin

Health‐related quality of life ‐ not measured · acute gout

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐1 inhibitors for acute gout 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Canakinumab vs triamcinolone acetonide

Health‐related quality of life ‐ not measured · acute gout

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐1 inhibitors for acute gout 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Health‐related quality of life ‐ not measured · patients with acute gout

The review found no eligible studies for this question.

1 finding from 1 review

Lifestyle interventions for acute gout 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Paliperidone palmitate vs placebo

Health‐related quality of life ‐ not measured · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Paliperidone palmitate for schizophrenia 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Xuezhikang vs pravastatin

Health‐related quality of life ‐ not reported · patients with hypercholesterolemia

The review found no eligible studies for this question.

1 finding from 1 review

Chinese herbal medicines for hypercholesterolemia 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Xuezhikang vs simvastatin

Health‐related quality of life ‐ not reported · patients with hypercholesterolemia

The review found no eligible studies for this question.

1 finding from 1 review

Chinese herbal medicines for hypercholesterolemia 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Erythrocytapheresis vs phlebotomy

Health‐related quality of life beyond one year · people with hereditary haemochromatosis

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hereditary haemochromatosis 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Health‐related quality of life and self esteem · preschool children (aged 0 to 6 years) with overweight or obesity

The review found no eligible studies for this question.

1 finding from 1 review

Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in preschool… 2016 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cephalomedullary nails vs extramedullary implants

Health‐related quality of life, early (≤ 4 months) · older adults (> 60 years of age) with extracapsular hip fractures

The review found no eligible studies for this question.

1 finding from 1 review

Cephalomedullary nails versus extramedullary implants for extracapsular hip fractures in older adults 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

NSAIDs vs glucocorticoids

HRQOL ‐ not measured · acute gout

The review found no eligible studies for this question.

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs for acute gout 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Metformin + megestrol vs megestrol

HRQOL ‐ not measured · endometrial hyerplasia

The review found no eligible studies for this question.

1 finding from 1 review

Metformin for endometrial hyperplasia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin vs megestrol

HRQOL ‐ not measured · endometrial hyperplasia

The review found no eligible studies for this question.

1 finding from 1 review

Metformin for endometrial hyperplasia 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Selenium (+LT4) vs placebo (+LT4)

Change from baseline in health‐related quality of life · participants with Hashimoto's thyroiditis.

The review found no eligible studies for this question.

1 finding from 1 review

Selenium supplementation for Hashimoto's thyroiditis 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Self‐reported health‐related quality of life post‐intervention · people with stroke

The review found no eligible studies for this question.

1 finding from 1 review

Telerehabilitation services for stroke 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Flutamide 250 mg once to b.i.d. vs spironolactone 100 mg

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Ethinyl estradiol 35 μg + cyproterone acetate 2 mg vs ethinyl estradiol 30 μg + desogestrel 0.15 mg

Change in health‐related quality of life (HRQOL) ‐ not measured · patients with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Spironolactone 100 mg vs placebo

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Finasteride 5 mg to 7.5 mg vs placebo

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Metformin 500 mg to 2550 mg per day vs placebo

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Finasteride 5 mg vs spironolactone 100 mg

Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found